B67.6 Echinococcus multilocularis infection, other and multiple sites

Name of the Condition

• Echinococcus multilocularis infection, other and multiple sites

Summary

Echinococcus multilocularis infection, other and multiple sites, is a parasitic condition caused by the tapeworm Echinococcus multilocularis. It involves the formation of alveolar cysts in organs beyond the liver or lungs, or in multiple sites simultaneously. This zoonotic infection is transmitted through ingestion of parasite eggs, which develop into invasive cysts that can cause tissue damage. The disease may be asymptomatic initially but can progress to severe complications depending on cyst location and size.

Causes

The infection is caused by ingesting eggs of Echinococcus multilocularis, which are shed in the feces of infected definitive hosts (typically foxes or other canids). These eggs contaminate soil, water, or food. Upon ingestion, the eggs hatch in the human intestine, releasing larvae that migrate to organs and develop into cysts. Unlike cystic echinococcosis, alveolar echinococcosis (caused by E. multilocularis) is characterized by infiltrative, tumor-like growth.

Risk Factors

• Living in or traveling to regions where the parasite is endemic (e.g., parts of North America, Europe, or Asia).
• Close contact with foxes or other definitive hosts, especially in rural or sylvatic settings.
• Ingesting food or water contaminated with parasite eggs.
• Occupational exposure, such as hunting, trapping, or wildlife handling.
• Lack of access to clean water or sanitation in endemic areas.

Symptoms

Symptoms depend on the affected organs and cyst size. Common manifestations include:

• Abdominal pain or mass (if involving the liver or gastrointestinal tract).
• Respiratory symptoms (e.g., cough, chest pain) if the lungs are affected.
• Neurological symptoms (e.g., headache, seizures) if the brain is involved.
• Generalized symptoms like fatigue, weight loss, or fever in advanced cases.

Diagnosis

Diagnosis involves a combination of imaging, serology, and histopathology. Imaging (e.g., CT, MRI, or ultrasound) identifies cystic lesions in affected organs. Serological tests detect antibodies to E. multilocularis. Biopsy or surgical specimens may be examined for characteristic cyst structures. Clinical correlation with exposure history is essential.

Treatment Options

Treatment typically includes antiparasitic medications (e.g., albendazole) to target the parasite. Surgical intervention may be necessary to remove cysts, especially in accessible sites. In advanced cases, a multidisciplinary approach involving surgery, medication, and supportive care is often required. Long-term therapy is common to prevent recurrence.

Prognosis and Follow-Up

Prognosis varies based on cyst location, extent of disease, and treatment response. Early diagnosis and treatment improve outcomes. Regular follow-up with imaging and serology is recommended to monitor for recurrence or complications. Lifelong surveillance may be necessary in some cases.

Complications

Potential complications include:

• Organ dysfunction due to cyst infiltration (e.g., liver failure, respiratory compromise).
• Cyst rupture, leading to anaphylaxis or dissemination.
• Secondary bacterial infections.
• Metastatic spread to other tissues.

Lifestyle & Prevention

• Avoid contact with wild animals, especially foxes, in endemic areas.
• Practice good hygiene, including handwashing after outdoor activities.
• Ensure food and water are safe, particularly when traveling to high-risk regions.
• Avoid consuming raw or undercooked meat from potentially infected animals.
• Use protective measures (e.g., gloves) when handling wildlife or animal feces.

When to Seek Professional Help

Seek medical attention if you experience unexplained abdominal pain, respiratory symptoms, or neurological issues, especially after travel to endemic regions or exposure to wild animals. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

Code B67.6 is assigned for Echinococcus multilocularis infection affecting sites other than the liver or lungs, or multiple sites simultaneously. Documentation should specify the affected organs or confirm multisite involvement. Ensure the diagnosis aligns with clinical findings and exposure history to support accurate coding.